Trial
NCT00707213
FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
National Institutes of Health (NIH); National Cancer Institute (NCI)
Condition
Cancer
Intervention
[18F]fluoro-2-deoxy-D-glucose (FDG)
Why stopped
Funding from the NIH ended and not all patients had been accrued
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-27